(Q37721269)

22 August 2017

1 reference

title

Th17 cells: positive or negative role in tumor? (English)

1 reference

22 August 2017

Yuqiang Ji

1

1 reference

PubMed ID

20352428

22 August 2017

Wanggang Zhang

series ordinal

2

1 reference

22 August 2017

30 March 2010

1 reference

Cancer Immunology, Immunotherapy

22 August 2017

1 reference

22 August 2017

59

1 reference

22 August 2017

7

1 reference

22 August 2017

979-987

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-010-0849-6

22 August 2017

0 references

cites work

[Th17 cells in human rheumatoid arthritis].

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

IL-23 promotes maintenance but not commitment to the Th17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Differential regulation of chemokines by IL-17 in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0849-6

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE04754

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE06880

Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1084/JEM.20081438

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE06881

Identifiers

DOI

10.1007/S00262-010-0849-6

1 reference

22 August 2017

1 reference

PubMed ID

20352428